Login to Your Account

Apitope Plans 2013 Financing to Advance Autoimmune Drugs

By Nuala Moran
Staff Writer

Wednesday, November 28, 2012
LONDON – Apitope Ltd. is busy drawing up the business plan for a double-digit financing round to take its next two projects through Phase I development after triggering a key clinical milestone in its lead multiple sclerosis program.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription